Clinical Trial

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

Study acronym: CONFLUENSE
Recruiting
View on ClinicalTrials.gov →
Summary
Objective of the study is to determine whether combined use of intraoperative fluorescence with 5-aminolevulinic acid (5-ALA) and sonography can achieve higher rate of gross total resection of contrast-enhancing gliomas and brain metastases compared to intraoperative fluorescence with 5-ALA alone.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-07-23; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2022-10-25
Trial Details
NCT Number NCT05474573
Lead Sponsor Sklifosovsky Institute of Emergency Care
Conditions Glioma, Malignant, Metastases to Brain
Enrollment 52 participants
Start Date 2022-09-01
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-16